Spontaneous conversion in patients with non-valvular atrial fibrillation planned for electrical cardioversion: A subanalysis of the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion Of Atrial Fibrillation (ENSURE-AF) trial

Am Heart J. 2019 Mar:209:131-135. doi: 10.1016/j.ahj.2018.10.008. Epub 2018 Nov 22.
No abstract available

Publication types

  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anticoagulants / administration & dosage
  • Atrial Fibrillation / complications
  • Atrial Fibrillation / physiopathology
  • Atrial Fibrillation / therapy*
  • Dose-Response Relationship, Drug
  • Electric Countershock / methods*
  • Factor Xa Inhibitors / administration & dosage
  • Female
  • Follow-Up Studies
  • Heart Rate / physiology*
  • Humans
  • Male
  • Middle Aged
  • Pyridines / administration & dosage*
  • Remission, Spontaneous
  • Retrospective Studies
  • Thiazoles / administration & dosage*
  • Thromboembolism / etiology
  • Thromboembolism / prevention & control
  • Treatment Outcome
  • Warfarin / administration & dosage*

Substances

  • Anticoagulants
  • Factor Xa Inhibitors
  • Pyridines
  • Thiazoles
  • Warfarin
  • edoxaban